5 July 2020

URV Activ@ - Diari digital de la Universitat Rovira i Virgili ·

Advanced search

Show all news

The European Commission has awarded the URV’s Martí i Franquès programme more than four million euros to be used to contract 50 predoctoral researchers. The selection process will take place over two editions in 2020 and 2021, and the chosen candidates will each be awarded a three-year contract. The university will contribute a further four million euros to the project. The URV is one of three institutions in Spain to have received funding in the last call of the European Commission’s COFUND-DP programme, and it is the one that has received the most money

A study by the URV’s Cheminformatics and Nutrition research group has shown that an anti-inflammatory drug for humans and another for animals inhibit a key enzyme in the replication and transcription of the COVID-19 virus. The results of the work have been validated by the initiative COVIDMoonshot which has carried out in vitro studies and assessed their bioactivity. The results have been published in the “International Journal of Molecular Sciences”